A novel functional variant (-842G>C) in the PIN1 promoter contributes to decreased risk of squamous cell carcinoma of the head and neck by diminishing the promoter activity

Carcinogenesis

Volumn 30, Issue 10, 2009, Pages 1717-1721

  Lu, Jiachun ^a   Hu, Zhibin ^a   Wei, Sheng ^a   Wang, Li E ^a   Liu, Zhensheng ^a   El Naggar, Adel K ^a   Sturgis, Erich M ^a   Wei, Qingyi ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE; GLUTAMINE; GLYCINE; PEPTIDYLPROLYL ISOMERASE PIN1; THREONINE;

ADULT; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENE ACTIVITY; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN VARIANT; REPORTER GENE; RISK REDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SQUAMOUS CELL CARCINOMA; TRANSCRIPTION REGULATION;

CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; ETHNIC GROUPS; GENE AMPLIFICATION; GENES, REPORTER; GENETIC VARIATION; GENOTYPE; HEAD AND NECK NEOPLASMS; HUMANS; MUTAGENESIS; PEPTIDYLPROLYL ISOMERASE; PLASMIDS; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; REFERENCE VALUES; RISK ASSESSMENT;

EID: 70350028604     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgp171     Document Type: Article

References (26)

1. Lu,K.P. (2004) Pinning down cell signaling, cancer and Alzheimer's disease. Trends Biochem. Sci., 29, 200-209.
2. Lu,K.P. (2003) Prolyl isomerase Pin1 as a molecular target for cancer diagnostics and therapeutics. Cancer Cell, 4, 175-180.
3. Wulf,G. et al. (2005) Phosphorylation-specific prolyl isomerization: Is there an underlying theme? Nat. Cell Biol., 7 435-441.
4. Ryo,A. et al. (2003) Prolyl isomerase Pin1: A catalyst for oncogenesis and a potential therapeutic target in cancer. J. Cell Sci., 116, 773-783.
5. Lu,K.P. et al. (1996) A human peptidyl-prolyl isomerase essential for regulation of mitosis. Nature, 380, 544-547.
6. Ranganathan,R. et al. (1997) Structural and functional analysis of the mitotic rotamase Pin1 suggests substrate recognition is phosphorylation dependent. Cell, 89, 875-886.
7. Ayala,G. et al. (2003) The prolyl isomerase Pin1 is a novel prognostic marker in human prostate cancer. Cancer Res., 63, 6244-6251.
8. Wulf,G.M. et al. (2001) Pin1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c-Jun towards cyclin D1. EMBO J., 20, 3459-3472.
9. Ryo,A. et al. (2001) Pin1 regulates turnover and subcellular localization of beta-catenin by inhibiting its interaction with APC. Nat. Cell Biol., 3, 793-801.
10. Miyashita,H. et al. (2003) Pin1 is overexpressed in oral squamous cell carcinoma and its levels correlate with cyclin D1 overexpression. Oncol. Rep., 10, 455-461.
11. Bao,L. et al. (2004) Prevalent overexpression of prolyl isomerase Pin1 in human cancers. Am. J. Pathol., 164, 1727-1737.
12. Ryo,A. et al. (2002) PIN1 is an E2F target gene essential for Neu/ Ras-induced transformation of mammary epithelial cells. Mol. Cell. Biol., 22, 5281-5295.
13. Ryo,A. et al. (2005) Stable suppression of tumorigenicity by Pin1-targeted RNA interference in prostate cancer. Clin. Cancer Res. 11, 7523-7531.
14. Brenkman,A.B. et al. (2008) The peptidyl-isomerase Pin1 regulates p27kip1 expression through inhibition of Forkhead box O tumor suppressors. Cancer Res., 68, 7597-7605.
15. Segat,L. et al. (2007) PIN1 promoter polymorphisms are associated with Alzheimer's disease. Neurobiol. Aging, 28, 69-74.
16. Segat,L. et al. (2007) PIN1 promoter polymorphisms in hepatocellular carcinoma patients. Gastroenterology, 132, 2618-2619.
17. Zheng,Y. et al. (2001) Cyclin D1 polymorphism and risk for squamous cell carcinoma of the head and neck: A case-control study. Carcinogenesis, 22, 1195-1199.
18. Shen,H. et al. (2002) P53 codon 72 polymorphism and risk of squamous cell carcinoma of the head and neck: A case-control study. Cancer Lett., 183, 123-130.
19. Li,G. et al. (2004) Association of a p73 exon 2 G4C14-to-A4T14 polymorphism with risk of squamous cell carcinoma of the head and neck. Carcinogenesis, 25, 1911-1916.
20. Lu,J. et al. (2007) 172G>T variant in the 5′ untranslated region of DNA repair gene RAD51 reduces risk of squamous cell carcinoma of the head and neck and interacts with a P53 codon 72 variant. Carcinogenesis, 28, 988-994.
21. Fujino,M. et al. (1995) Prognostic significance of p53 and Ras p21 expression in nonsmall cell lung cancer. Cancer, 76, 2457-2463.
22. Liou,Y.C. et al. (2002) Loss of Pin1 function in the mouse causes phenotypes resembling cyclin D1-null phenotypes. Proc. Natl Acad. Sci. USA, 99, 1335-1340.
23. Yeh,E.S. et al. (2007) PIN1, the cell cycle and cancer. Nat. Rev. Cancer, 7, 381-388.
24. Pang,R. et al. (2007) PIN1 interacts with a specific serine-proline motif of hepatitis B virus x-protein to enhance hepatocarcinogenesis. Gastroenterology, 132, 1088-1103.
25. Ernster,J.A. et al. (2007) Rising incidence of oropharyngeal cancer and the role of oncogenic human papilloma virus. Laryngoscope 117, 2115-2128.
26. Lambert,J.C. et al. (2006) Association study of the PIN1 gene with Alzheimer's disease. Neurosci. Lett., 402, 259-261.